Boshen Jiao

Department Associate

Global Health and Population

bjiao@hsph.harvard.edu

Links

Catalyst Profile

Overview

Education and Training
Awards and Honors

PhD, 08/2022, Health Economics and Outcomes Research
University of Washington , Seattle

Best General Research Podium Presentation Award, ISPOR2023

Graduate Student Conference Presentation Award, UW2022

Rubenstein Endowment Award, University of Washington (UW)2022

Lee B. Lusted Prize, Society for Medical Decision Making2022

Louis Sr. and Marilyn Garrison Endowed Prize in Health Policy and Economics, UW2021

Rubenstein Endowment Award, UW2020

Louis Sr. and Marilyn Garrison Endowed Prize in Health Policy and Economics, UW2020

Eli Lilly Predoctoral Endowed Fellowship, UW2018

International Masters Mobility Scholarship, Université Sorbonne Paris Cité2016

Bibliography

Association between achieving adequate antenatal care and health-seeking behaviors: A study of Demographic and Health Surveys in 47 low- and middle-income countries.

Jiao B, Iversen I, Sato R, Pecenka C, Khan S, Baral R, Kruk ME, Arsenault C, Verguet S.

PLoS Med. 2024 Jul. 21(7):e1004421. PMID: 38968303

Lifetime Health and Economic Outcomes of Biparametric Magnetic Resonance Imaging as First-Line Screening for Prostate Cancer : A Decision Model Analysis.

Gulati R, Jiao B, Al-Faouri R, Sharma V, Kaul S, Fleishman A, Wymer K, Boorjian SA, Olumi AF, Etzioni R, Gershman B.

Ann Intern Med. 2024 Jul. 177(7):871-881. PMID: 38830219

Estimating the Allocation of the Economic Value Generated by Utilization of All-Oral Direct-Acting Antivirals for Hepatitis C in the United States, 2015 to 2019.

Garrison LP, Jiao B, Elsisi Z, Yehoshua A, Koruth R, Kreter B, Grueger J.

Value Health. 2024 Aug. 27(8):1021-1029. PMID: 38663800

Health Interventions May Have Divergent Impacts on Health and Economic Equity: A Case Study of the Community-Based Hypertension Improvement Project in Ghana.

Liang Y, Lin Y, Jiao B.

Appl Health Econ Health Policy. 2024 May. 22(3):353-362. PMID: 38267804

Gene Therapy Versus Common Care for Eligible Individuals With Sickle Cell Disease in the United States : A Cost-Effectiveness Analysis.

Basu A, Winn AN, Johnson KM, Jiao B, Devine B, Hankins JS, Arnold SD, Bender MA, Ramsey SD.

Ann Intern Med. 2024 02. 177(2):155-164. PMID: 38252942

Evaluating Policies of Expanding Versus Restricting First-Line Treatment Choices: A Cost-Effectiveness Analysis Framework.

Jiao B, Carlson JJ, Garrison LP, Basu A.

Value Health. 2024 04. 27(4):433-440. PMID: 38191022

Estimating the Potential Benefits of Confirmatory Trials for Drugs with Accelerated Approval: A Comprehensive Value of Information Framework.

Jiao B.

Pharmacoeconomics. 2023 Dec. 41(12):1617-1627. PMID: 37490206

Long-term survival with sickle cell disease: a nationwide cohort study of Medicare and Medicaid beneficiaries.

Jiao B, Johnson KM, Ramsey SD, Bender MA, Devine B, Basu A.

Blood Adv. 2023 07 11. 7(13):3276-3283. PMID: 36929166

Gender Disparities in Blood Pressure and the Role of Body Mass Index: A Birth Cohort Analysis in China.

Wu J, Jiao B, Zhao J.

J Epidemiol Glob Health. 2023 09. 13(3):485-494. PMID: 37302107

Associating Health-Related Quality-of-Life Score with Time Uses to Inform Productivity Measures in Cost-Effectiveness Analysis.

Jiao B, Basu A.

Pharmacoeconomics. 2023 09. 41(9):1065-1077. PMID: 36877451

VIEW MORE PUBLICATIONS